Tag
NASDAQ: GH
- Natera receives FDA breakthrough designation for multi-cancer blood test
- Guardant Health gains European CE mark for ESR1 breast cancer test
- Cambridge researchers develop urine test that could detect lung cancer years earlier
- Tempus AI, Daiichi Sankyo team up to boost cancer drug trials with AI
- Guardant Health launches multi-cancer blood test in Asia through Manulife partnership
- bioAffinity launches 2,000‑patient study for noninvasive lung cancer test
- Nearly four in ten global cancer cases are preventable, WHO analysis finds
- BioMark earns peer-reviewed validation for AI‑driven lung cancer detection model
- Imperial College and Pancreatic Cancer UK begin 6,000 patient breath test study
- SmartPath Uses AI to personalize cancer care across Asia
- Evaxion shares spike as AI‑designed melanoma vaccine data hits market
- McMaster surgeon develops AI tool to reduce invasive lung biopsies
- University of Warwick uses diamonds to help trace metastasis in cancer
- Guardant Health gets Breakthrough Device Designation from FDA for cancer detection test
- Australian biotech uncovers broader view of tumour genetics with liquid biopsy
- Phase Scientific International advances urine biopsy tech with $34M fundraising round
- New Korean cancer tech finds mutations with only a few drops of blood
- Korean medical technology company incorporates AI into lung cancer diagnosis
- Lung cancer isn't just for smokers anymore: European study